MADRIGAL PHARMACEUTICALS, INC.·4

Mar 7, 4:50 PM ET

Kelley Shannon T 4

4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Mar 7, 2025

Insider Transaction Report

Form 4
Period: 2025-03-05
Kelley Shannon T
General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-03-05+5,3685,368 total
    Exercise: $347.28Exp: 2035-03-05Common Stock (5,368 underlying)
  • Award

    Common Stock

    2025-03-05+3,18710,477 total
Footnotes (2)
  • [F1]Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 5, 2026, March 5, 2027, March 5, 2028 and March 5, 2029, provided the Reporting Person continues in service with the Issuer on each such date.
  • [F2]The option vests as to 25% of the shares on the first anniversary of the date of grant (March 5, 2026) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.

Documents

1 file
  • 4
    wk-form4_1741384239.xmlPrimary

    FORM 4